Sernova Biotherapeutics (HAM:PSH0) FCF Yield %: -10.81 (As of Jun. 30, 2026)


HAM:PSH0 Sernova Biotherapeutics Inc HAM:PSH0
30 GF Score
Price €0.06
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics FCF Yield %?

Sernova Biotherapeutics HAM:PSH0 +3.30% 30 FCF Yield % is -10.81 as of Jun. 30, 2026. GuruFocus rates HAM:PSH0 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,415 Biotechnology companies, Sernova Biotherapeutics ranks worse than 53.22% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Sernova Biotherapeutics's Trailing 12-Month Free Cash Flow is €-3.42 Mil, and Market Cap is €31.53 Mil. Therefore, Sernova Biotherapeutics's FCF Yield % for today is -10.81%.

The historical rank and industry rank for Sernova Biotherapeutics's FCF Yield % or its related term are showing as below:

HAM:PSH0' s FCF Yield % Range Over the Past 10 Years
Min: -10.81   Med: 0   Max: 0
Current: -10.81

HAM:PSH0's FCF Yield % is ranked worse than
53.22% of 1415 companies
in the Biotechnology industry
Industry Median: -9.49 vs HAM:PSH0: -10.81

Sernova Biotherapeutics's FCF Margin % for the quarter that ended in Apr. 2026 was 0.00%.

Sernova Biotherapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Sernova Biotherapeutics FCF Yield % Related Terms

Sernova Biotherapeutics FCF Yield % Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics FCF Yield % Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -20.96

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -1.31 -7.88 -14.05

HAM:PSH0 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Sernova Biotherapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's FCF Yield % falls into.


HAM:PSH0
30GF Score
Sernova Biotherapeutics Inc HAM:PSH0
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Sernova Biotherapeutics's FCF Yield % for the fiscal year that ended in Oct. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.699 / 31.95408
=-20.96%

Sernova Biotherapeutics's annualized FCF Yield % for the quarter that ended in Apr. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.373 * 4 / 39.0860505
=-14.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -10.81 mean?
Sernova Biotherapeutics (HAM:PSH0) has a FCF Yield % of -10.81 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Sernova Biotherapeutics and its competitors. According to the industry distribution chart, Sernova Biotherapeutics ranks #753 out of 1415 companies in the Biotechnology industry, placing it in the top 53.2%.
Is Sernova Biotherapeutics' FCF Yield % too high?
Sernova Biotherapeutics' current FCF Yield % is -10.81. Based on the distribution chart, Sernova Biotherapeutics ranks #753 out of 1415 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sernova Biotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sernova Biotherapeutics ranks #753 out of 1415 companies for FCF Yield %. This places Sernova Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current FCF Yield % is -10.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (HAM:PSH0) has a current FCF Yield % of -10.81. The current FCF Yield % is -10.81. Sernova Biotherapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Sernova Biotherapeutics (HAM:PSH0), the current FCF Yield % is -10.81 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
30GF Score

Get the complete analysis for HAM:PSH0

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price